The mechanisms of angiogenesis in hepatocellular carcinoma: Angiogenic switch during tumor progression
Tài liệu tham khảo
Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7
Folkman, 1995, Angiogenesis in cancer, vascular, rheumatoid and other disease, Nat Med, 1, 27, 10.1038/nm0195-27
Gale, 1999, Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development, Genes Dev, 13, 1055, 10.1101/gad.13.9.1055
Ferrara, 1999, Clinical applications of angiogenic growth factors and their inhibitors, Nat Med, 5, 1359, 10.1038/70928
Holash, 1999, Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF, Science, 284, 1994, 10.1126/science.284.5422.1994
Honda, 2000, Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules, J Hepatobiliary Pancreat Surg, 7, 245, 10.1007/s005340070044
Maeda, 1995, CD34 expression in endothelial cells of small hepatocellular carcinoma: its correlation with tumour progression and angiographic findings, J Gastroenterol Hepatol, 10, 650, 10.1111/j.1440-1746.1995.tb01365.x
Sonoda, 1989, Angiographically undetected small hepatocellular carcinoma: clinicopathological characteristics, follow-up and treatment, Hepatology, 10, 1003, 10.1002/hep.1840100619
Sakamoto, 1993, Phenotype changes in tumor vessels associated with the progression of hepatocellular carcinoma, Jpn J Clin Oncol, 23, 98
Folkman, 1998, Antiangiogenic gene therapy, Proc Natl Acad Sci U S A, 95, 9064, 10.1073/pnas.95.16.9064
Ferrara, 1997, The biology of vascular endothelial growth factor, Endocr Rev, 18, 4, 10.1210/er.18.1.4
Kukk, 1996, VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development, Development, 122, 3829, 10.1242/dev.122.12.3829
Leung, 1989, Vascular endothelial growth factor is a secreted angiogenic mitogen, Science, 246, 1306, 10.1126/science.2479986
Shweiki, 1992, Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis, Nature, 359, 843, 10.1038/359843a0
Gleadle, 1998, Hypoxia and the regulation of gene expression, Mol Med Today, 4, 122, 10.1016/S1357-4310(97)01198-2
Pertovaara, 1994, Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells, J Biol Chem, 269, 6271, 10.1016/S0021-9258(17)37365-9
Kieser, 1994, Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression, Oncogene, 9, 963
Rak, 1995, Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis, Cancer Res, 55, 4575
Mise, 1996, Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor, Hepatology, 23, 455, 10.1002/hep.510230309
Suzuki, 1996, Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma, Cancer Res, 56, 3004
Kawahara, 1998, Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma, Hepatology, 28, 1512, 10.1002/hep.510280610
El-Assal, 1998, Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver, Hepatology, 27, 1554, 10.1002/hep.510270613
Shimoda, 1999, Vascular endothelial growth factor/vascular permeability factor mRNA expression in patients with chronic hepatitis C and hepatocellular carcinoma, Int J Oncol, 14, 353
Okuda, 2000, Hepatocellular carcinoma, J Hepatol, 32, 225, 10.1016/S0168-8278(00)80428-6
Yamaguchi, 1998, Expression of vascular endothelial growth factor in human hepatocellular carcinoma, Hepatology, 28, 68, 10.1002/hep.510280111
Davis, 1996, Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning, Cell, 87, 1161, 10.1016/S0092-8674(00)81812-7
Sato, 1993, Tie-1 and tie-2 define another class of putative receptor tyrosine kinase genes expressed in early embryonic vascular system, Proc Natl Acad Sci U S A, 90, 9355, 10.1073/pnas.90.20.9355
Maisonpierre, 1997, Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis, Science, 277, 55, 10.1126/science.277.5322.55
Suri, 1996, Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis, Cell, 87, 1171, 10.1016/S0092-8674(00)81813-9
Fachinger, 1999, Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2, Oncogene, 18, 5948, 10.1038/sj.onc.1202992
Stratmann, 1998, Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis, Am J Pathol, 153, 1459, 10.1016/S0002-9440(10)65733-1
Brown, 2000, Expression of tie1, tie2, and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma, Am J Pathol, 156, 2179, 10.1016/S0002-9440(10)65088-2
Peters, 1998, Expression of Tie2/Tek in breast tumour vasculature provides a new marker for evaluation of tumour angiogenesis, Br J Cancer, 77, 51, 10.1038/bjc.1998.8
Tanaka, 1999, Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma, J Clin Invest, 103, 341, 10.1172/JCI4891
Yamashita, 2001, Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model, Cancer Res, 61, 1005
Kim, 1998, Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma, Cancer Res, 58, 348
Lin, 1998, Anti-angiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2, Proc Natl Acad Sci U S A, 95, 8829, 10.1073/pnas.95.15.8829
Kin, 2000, Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats, Int J Oncol, 16, 375